tiprankstipranks
Trending News
More News >
Entheon Biomedical (ENTBF)
OTHER OTC:ENTBF
Advertisement

Entheon Biomedical (ENTBF) Price & Analysis

Compare
34 Followers

ENTBF Stock Chart & Stats


Entheon Biomedical News

ENTBF FAQ

What was Entheon Biomedical’s price range in the past 12 months?
Entheon Biomedical lowest stock price was $0.04 and its highest was $0.29 in the past 12 months.
    What is Entheon Biomedical’s market cap?
    Entheon Biomedical’s market cap is $1.06M.
      When is Entheon Biomedical’s upcoming earnings report date?
      Entheon Biomedical’s upcoming earnings report date is Oct 23, 2025 which is in 78 days.
        How were Entheon Biomedical’s earnings last quarter?
        Entheon Biomedical released its earnings results on Jul 18, 2025. The company reported -$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.004.
          Is Entheon Biomedical overvalued?
          According to Wall Street analysts Entheon Biomedical’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Entheon Biomedical pay dividends?
            Entheon Biomedical does not currently pay dividends.
            What is Entheon Biomedical’s EPS estimate?
            Entheon Biomedical’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Entheon Biomedical have?
            Entheon Biomedical has 13,858,926 shares outstanding.
              What happened to Entheon Biomedical’s price movement after its last earnings report?
              Entheon Biomedical reported an EPS of -$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Entheon Biomedical?
                Currently, no hedge funds are holding shares in ENTBF

                Company Description

                Entheon Biomedical

                Entheon Biomedical Corp. operates as a biotechnology research and drug development company. It engages in developing and commercializing various N,N-dimethyltryptamine based psychedelic therapeutic products for treating addiction and substance use disorders. The company serves physicians, clinics, and licensed psychiatrists in Canada, the United States, and European Union. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.

                Entheon Biomedical (ENTBF) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Cybin
                Braxia Scientific
                Lexston Life Sciences Corp.
                Doseology Sciences
                Lophos Holdings, Inc.

                Ownership Overview

                5.48%94.52%
                ― Other Institutional Investors
                94.52% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis